| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT07603479 JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced… |
Recruitment opened |
| 2026-08-07 | NCT07483970 A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With… |
Recruitment opened |
| 2026-08-07 | NCT07579741 A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders |
Recruitment opened |
| 2026-08-07 | NCT07579741 A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders |
date change Primary completion moved earlier: 2027-07-21 -> 2027-02-12 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT07579741 | A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders | HIV Infections | Recruiting |
| NCT07501559 | A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in… | Recurrent Glioblastoma Multiforme(GBM) | Recruiting |
| Phase 1 | |||
| NCT07623850 | A Phase I Study of JLM019 Injection | Advanced Solid Tumor (Phase 1) | Recruiting |
| NCT07483970 | A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With… | High Risk Non-muscle Invasive Bladder Cancer | Recruiting |
| NCT07603479 | JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced… | Malignancies | Recruiting |
| NCT07443228 | Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological… | HIV | Not Yet Recruiting |